» Articles » PMID: 37429047

Visible Light-induced 3D Bioprinted Injectable Scaffold for Minimally Invasive Tissue Regeneration

Overview
Journal Biomater Adv
Date 2023 Jul 10
PMID 37429047
Authors
Affiliations
Soon will be listed here.
Abstract

Pre-formed hydrogel scaffolds have emerged as favorable vehicles for tissue regeneration, promoting minimally invasive treatment of native tissue. However, due to the high degree of swelling and inherently poor mechanical properties, development of complex structural hydrogel scaffolds at different dimensional scales has been a continuous challenge. Herein, we take a novel approach at the intersections of engineering design and bio-ink chemistry to develop injectable pre-formed structural hydrogel scaffolds fabricated via visible light (VL) induced digital light processing (DLP). In this study, we first determined the minimum concentration of poly(ethylene glycol) diacrylate (PEGDA) to be added to the gelatin methacrylate (GelMA) bio-ink in order to achieve scalable and high printing-fidelity with desired cell adhesion, viability, spreading, and osteogenic differentiation characteristics. Despite the advantages of hybrid GelMA-PEGDA bio-ink in improving scalability and printing-fidelity, compressibility, shape-recovery, and injectability of the 3D bioprinted scaffolds were compromised. To restore these needed characteristics for minimally invasive tissue regeneration applications, we performed topological optimization to design highly compressible and injectable pre-formed (i.e., 3D bioprinted) microarchitectural scaffolds. The designed injectable pre-formed microarchitectural scaffolds showed a great capacity to retain the viability of the encapsulated cells (>72 % after 10 cycles of injection). Lastly, ex ovo chicken chorioallantoic membrane (CAM) studies revealed that the optimized injectable pre-formed hybrid hydrogel scaffold is biocompatible and supports angiogenic growth.

Citing Articles

Raising the Bar: Progress in 3D-Printed Hybrid Bone Scaffolds for Clinical Applications: A Review.

Khan A, Grewal N, Jun Z, Tawfiq F, Tchier F, Zulqarnain R Cell Transplant. 2024; 33:9636897241273562.

PMID: 39517106 PMC: 11549696. DOI: 10.1177/09636897241273562.


3D Bioprinting for Engineered Tissue Constructs and Patient-Specific Models: Current Progress and Prospects in Clinical Applications.

Lee S, Jeong W, Atala A Adv Mater. 2024; 36(49):e2408032.

PMID: 39420757 PMC: 11875024. DOI: 10.1002/adma.202408032.

References
1.
Xu P, Guan J, Chen Y, Xiao H, Yang T, Sun H . Stiffness of photocrosslinkable gelatin hydrogel influences nucleus pulposus cell propertiesin vitro. J Cell Mol Med. 2020; 25(2):880-891. PMC: 7812302. DOI: 10.1111/jcmm.16141. View

2.
Zhao Q, Cui H, Wang J, Chen H, Wang Y, Zhang L . Regulation Effects of Biomimetic Hybrid Scaffolds on Vascular Endothelium Remodeling. ACS Appl Mater Interfaces. 2018; 10(28):23583-23594. DOI: 10.1021/acsami.8b06205. View

3.
Cai Z, Wan Y, Becker M, Long Y, Dean D . Poly(propylene fumarate)-based materials: Synthesis, functionalization, properties, device fabrication and biomedical applications. Biomaterials. 2019; 208:45-71. DOI: 10.1016/j.biomaterials.2019.03.038. View

4.
Mangir N, Dikici S, Claeyssens F, MacNeil S . Using Chick Chorioallantoic Membrane (CAM) Assay To Evaluate the Biocompatibility and Angiogenic Response to Biomaterials. ACS Biomater Sci Eng. 2021; 5(7):3190-3200. DOI: 10.1021/acsbiomaterials.9b00172. View

5.
Yue K, Trujillo-de Santiago G, Alvarez M, Tamayol A, Annabi N, Khademhosseini A . Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015; 73:254-71. PMC: 4610009. DOI: 10.1016/j.biomaterials.2015.08.045. View